Objectives:
1:Participants will become familiar with dosing routes and formulations of ketamine and their application to mental health treatment.
2:Participants will be able to discuss the advantages of ketamine treatment over conventional antidepressant pharmacotherapy.
3:Participants will be able to discuss the potential therapeutic advantage of medicine assisted psychotherapy compared to psychotherapy and medication treatment separately.
This session is accredited for a maximum of 1.0 AOA Category 1-A credits. Credits commensurate with participation in the session will be awarded.
MOA Grievance Policy: All grievances should be initially directed in writing to the MOA Executive Director by email to info@mainedo.org who will share them with the MOA's Program Committee. Grievances will receive a response within 30 days of receipt. If you do not receive a satisfactory response, you may notify the Council on Continuing Medical Education, AOA, 142 East Ontario St., Chicago, IL 60611.